Insider Trading & Ownership - Gano Kyle

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Gano Kyle
Common stock purchase or sale:
Transaction
Date		 Reported
DateTime		 Company Symbol Insider
Relationship		 Shares
Traded		 Average
Price		 Total
Amount		 Shares
Owned		 Filing
2025-02-13
Sale		 2025-02-14
6:20 pm		 NEUROCRINE BIOSCIENCES INC NBIX Gano Kyle
Chief Executive Officer		 2,558 $116.85 $298,908 276,128
(Direct)		 View
2025-02-10
Sale		 2025-02-12
6:48 pm		 NEUROCRINE BIOSCIENCES INC NBIX Gano Kyle
Chief Executive Officer		 980 $118.39 $116,020 137,658
(Direct)		 View
2025-01-31
Sale		 2025-02-04
5:47 pm		 NEUROCRINE BIOSCIENCES INC NBIX Gano Kyle
Chief Executive Officer		 1,541 $152.87 $235,577 139,705
(Direct)		 View
2025-01-15
Sale		 2025-01-17
4:32 pm		 NEUROCRINE BIOSCIENCES INC NBIX Gano Kyle
Chief Executive Officer		 65,000 $141.5 $9,197,550 135,392
(Direct)		 View
2024-02-13
Sale		 2024-02-15
5:40 pm		 NEUROCRINE BIOSCIENCES INC NBIX Gano Kyle
Chief Business Development Off		 1,352 $132.89 $179,674 189,190
(Direct)		 View
2024-02-06
Sale		 2024-02-08
7:17 pm		 NEUROCRINE BIOSCIENCES INC NBIX Gano Kyle
Chief Business Development Off		 2,580 $139.16 $359,041 133,952
(Direct)		 View
2024-01-31
Sale		 2024-02-02
7:17 pm		 NEUROCRINE BIOSCIENCES INC NBIX Gano Kyle
Chief Business Development Off		 1,541 $140.7 $216,813 131,635
(Direct)		 View
2024-01-02
Sale		 2024-01-04
6:32 pm		 NEUROCRINE BIOSCIENCES INC NBIX Gano Kyle
Chief Business Development Off		 75,000 $131.47 $9,860,194 130,250
(Direct)		 View
2023-08-21
Sale		 2023-08-23
8:05 pm		 NEUROCRINE BIOSCIENCES INC NBIX Gano Kyle
Chief Business Development Off		 2,132 $107.41 $228,993 130,250
(Direct)		 View
2023-02-06
Sale		 2023-02-08
7:25 pm		 NEUROCRINE BIOSCIENCES INC NBIX Gano Kyle
Chief Business Development Off		 17,004 $102.79 $1,747,920 128,096
(Direct)		 View
2023-01-31
Sale		 2023-02-02
5:15 pm		 NEUROCRINE BIOSCIENCES INC NBIX Gano Kyle
Chief Business Development Off		 1,541 $109.98 $169,486 112,820
(Direct)		 View
2022-02-07
Sale		 2022-02-09
6:58 pm		 NEUROCRINE BIOSCIENCES INC NBIX Gano Kyle
Chief Business Development Off		 6,880 $80.61 $554,628 111,173
(Direct)		 View
2022-01-05
Sale		 2022-01-07
6:04 pm		 NEUROCRINE BIOSCIENCES INC NBIX Gano Kyle
Chief Business Development Off		 28,266 $85.5 $2,416,751 104,984
(Direct)		 View
2021-02-05
Sale		 2021-02-09
9:42 pm		 NEUROCRINE BIOSCIENCES INC NBIX Gano Kyle
Chief Business Development Off		 6,370 $115.65 $736,702 156,839
(Direct)		 View
2020-11-12
Sale		 2020-11-16
6:11 pm		 NEUROCRINE BIOSCIENCES INC NBIX Gano Kyle
Chief Business Development Off		 2,257 $90.73 $204,770 98,028
(Direct)		 View
2020-08-05
Sale		 2020-08-07
7:24 pm		 NEUROCRINE BIOSCIENCES INC NBIX Gano Kyle
Chief Business Development Off		 2,257 $118.87 $268,286 95,997
(Direct)		 View
2020-04-24
Sale		 2020-04-28
8:40 pm		 NEUROCRINE BIOSCIENCES INC NBIX Gano Kyle
Chief Business Development Off		 1,934 $99.47 $192,377 93,967
(Direct)		 View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		 Reported
DateTime		 Exercisable
Expiration		 Company Symnbol Insider
Relationship		 Shares
Traded		 Conversion
Price		 Shares
Owned		 Filing
2025-02-13
Exercise		 2025-02-14
6:20 pm		 N/A
N/A		 NEUROCRINE BIOSCIENCES INC NBIX Gano Kyle
Chief Executive Officer		 4,807 $0 276,128
(Direct)		 View
2025-02-12
Option Award		 2025-02-14
6:20 pm		 N/A
2035-02-12		 NEUROCRINE BIOSCIENCES INC NBIX Gano Kyle
Chief Executive Officer		 124,364 $0 276,128
(Direct)		 View
2025-02-08
Exercise		 2025-02-12
6:48 pm		 N/A
N/A		 NEUROCRINE BIOSCIENCES INC NBIX Gano Kyle
Chief Executive Officer		 1,860 $0 137,658
(Direct)		 View
2025-01-31
Exercise		 2025-02-04
5:47 pm		 N/A
N/A		 NEUROCRINE BIOSCIENCES INC NBIX Gano Kyle
Chief Executive Officer		 2,927 $0 139,705
(Direct)		 View
2025-01-15
Exercise		 2025-01-17
4:32 pm		 N/A
2025-02-03		 NEUROCRINE BIOSCIENCES INC NBIX Gano Kyle
Chief Executive Officer		 65,000 $0 135,392
(Direct)		 View
2025-01-15
Exercise		 2025-01-17
4:32 pm		 N/A
N/A		 NEUROCRINE BIOSCIENCES INC NBIX Gano Kyle
Chief Executive Officer		 65,000 $32.99 135,392
(Direct)		 View
2024-11-01
Option Award		 2024-11-01
7:52 pm		 N/A
N/A		 NEUROCRINE BIOSCIENCES INC NBIX Gano Kyle
Chief Executive Officer		 15,799 $0 15,799
(Direct)		 View
2024-02-13
Option Award		 2024-02-15
5:40 pm		 N/A
2034-02-13		 NEUROCRINE BIOSCIENCES INC NBIX Gano Kyle
Chief Business Development Off		 54,024 $0 189,190
(Direct)		 View
2024-01-02
Exercise		 2024-01-04
6:32 pm		 N/A
2024-01-16		 NEUROCRINE BIOSCIENCES INC NBIX Gano Kyle
Chief Business Development Off		 75,000 $19.59 130,250
(Direct)		 View
2023-02-13
Option Award		 2023-02-15
7:10 pm		 N/A
2033-02-13		 NEUROCRINE BIOSCIENCES INC NBIX Gano Kyle
Chief Business Development Off		 74,053 $0 74,053
(Direct)		 View
2022-01-31
Option Award		 2022-02-02
8:02 pm		 N/A
2032-01-31		 NEUROCRINE BIOSCIENCES INC NBIX Gano Kyle
Chief Business Development Off		 91,426 $0 91,426
(Direct)		 View
2022-01-05
Exercise		 2022-01-07
6:04 pm		 N/A
2022-01-12		 NEUROCRINE BIOSCIENCES INC NBIX Gano Kyle
Chief Business Development Off		 28,266 $8.66 104,984
(Direct)		 View
2021-02-08
Option Award(A)		 2021-03-29
06:15 am		 N/A
2031-02-08		 NEUROCRINE BIOSCIENCES INC NBIX Gano Kyle
Chief Business Development Off		 49,049 $0 49,049
(Direct)		 View
2021-02-08
Option Award		 2021-02-09
9:42 pm		 N/A
2031-02-08		 NEUROCRINE BIOSCIENCES INC NBIX Gano Kyle
Chief Business Development Off		 52,071 $0 156,839
(Direct)		 View
(A) Indicate amendment filing.